EUVIMEDEUVIMED entdecken
Systematische Übersicht

Cancer Drug Wastage and Mitigation Methods: A Systematic Review

Krishna Sabareesh Rajangom, F Safa Erenay, Qi-Ming He, Rachel Figueiredo, Kelvin K W Chan, Matthew C Cheung, Lauren F Charbonneau, Susan E Horton, Avram Denburg

Value in Health · 2025-01 · 28 (1) · 148-160

DOI: 10.1016/j.jval.2024.08.006 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Value in Health, 2025-01. Verfasst von Krishna Sabareesh Rajangom und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Management Sciences, University of Waterloo, Waterloo, ON, Canada. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 131 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To systematically review published evidence on cancer drug wastage and the effectiveness of mitigation methods. METHODS: Search keywords for Scopus, PubMed, and EMBASE were developed using the Pearl Growing technique. Relevant articles were identified in a 2-step process: first, based on titles/abstracts, then on full article reviews. Among the identified English peer-reviewed articles, those considering adults ≥18 years and relevant cancer drug wastage outcomes were included. Key concepts and measures for drug wastage and its mitigation were tabulated. Trends in publication numbers were analyzed using Mann-Kendall tests. Costs were converted first to 2024 local currencies using country-wise consumer price indexes and then to 2024 USD using exchange rates. RESULTS: Among 6298 unique articles, 94 met the inclusion criteria. Seventy-four (79%) of these were published since 2015, highlighting increasing attention to cancer drug wastage. Twenty-three articles (24%) explicitly reported drug wastage amounts, whereas 52 articles (55%) considered the mitigation methods. Most articles focused on high-income countries (n = 67), single-hospital settings (n = 45), and retrospective study designs (n = 55). Wastage mitigation techniques included vial sharing (n = 21), dose rounding (n = 17), closed-system transfer device (n = 9), centralized drug preparation (n = 7), and vial size optimization (n = 7). A trend toward higher median wastage cost was evident in US settings ($135.35/patient-month) compared with other countries ($37.71/patient-month), whereas mitigation methods across countries were not statistically significant. CONCLUSIONS: High cancer drug costs highlight the importance of minimizing drug wastage to reduce healthcare expenditure. Our review demonstrates that wastage varies by healthcare setting and mitigation technique. Future studies would benefit from reporting standards for cancer drug wastage that include reporting wastage (both in mg and cost, preferably in terms of purchase power parity), as well as cohort size, considered vial sizes, considered dosages, and used mitigation methods separately for each drug. This approach would account for variability in cancer drug wastage and help identify optimal mitigation practices tailored to the health system context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsHumansDrug CostsNeoplasms

Stichwörter der Autor:innen

cancer drugsdrug wastage and mitigationmeta-analysisreducing healthcare costssystematic review

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Management Sciences, University of Waterloo, Waterloo, ON, Canada.
  • Department of Information Services and Resources, University of Waterloo, Waterloo, ON, Canada.
  • Odette Cancer Center, Sunnybrook Health Sciences Center, Toronto, ON, Canada.
  • School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada.
  • Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada. Electronic address: avram.denburg@sickkids.ca.

Förderung

  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Rajangom, K. S., Erenay, F. S., He, Q. M., Figueiredo, R., Chan, K. K. W., Cheung, M. C., Charbonneau, L. F., Horton, S. E., & Denburg, A. (2025). Cancer Drug Wastage and Mitigation Methods: A Systematic Review. Value in Health, 28(1), 148-160. https://doi.org/10.1016/j.jval.2024.08.006

Vancouver

Rajangom KS, Erenay FS, He QM, Figueiredo R, Chan KKW, Cheung MC, et al. Cancer Drug Wastage and Mitigation Methods: A Systematic Review. Value in Health. 2025;28(1):148-160. doi:10.1016/j.jval.2024.08.006

BibTeX
@article{Rajangom2025,
  author = {Rajangom, Krishna Sabareesh and Erenay, F Safa and He, Qi-Ming and Figueiredo, Rachel and Chan, Kelvin K W and Cheung, Matthew C and Charbonneau, Lauren F and Horton, Susan E and Denburg, Avram},
  title = {Cancer Drug Wastage and Mitigation Methods: A Systematic Review},
  journal = {Value in Health},
  year = {2025},
  volume = {28},
  number = {1},
  pages = {148--160},
  doi = {10.1016/j.jval.2024.08.006}
}
Kostenlos starten →